The laboratory of Anie Philip has reported that CD109 expression is elevated in skin samples from patients with systemic sclerosis (SSc)/scleroderma, as well as in skin fibroblasts cultured from SSc patients [69]. This evidence concerns the gene CD109 and scleroderma.